Advanced Biohealing

Advanced BioHealing, Inc. was a regenerative medicine company best known for Dermagraft, a cryopreserved human fibroblast-derived dermal substitute used to treat diabetic foot ulcers. The company acquired the Dermagraft assets from Smith & Nephew in 2006, was backed by Canaan Partners and other venture investors, and was acquired by Shire plc for $750 million in cash in June 2011 to seed Shire's regenerative medicine business unit. Dermagraft was later sold to Organogenesis in 2014. Advanced BioHealing no longer operates as an independent entity and publishes no public developer portal, API, or programmatic surface; this profile is retained in the API Evangelist network as a venture-portfolio company record.

Advanced Biohealing is profiled on the APIs.io network. Tagged areas include Company, Regenerative Medicine, Biotechnology, Medical Devices, and Healthcare.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyRegenerative MedicineBiotechnologyMedical DevicesHealthcareWound CareLife SciencesVenture Portfolio

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/advanced-biohealing: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

aid: advanced-biohealing
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/advanced-biohealing.png
name: Advanced Biohealing
description: Advanced BioHealing, Inc. was a regenerative medicine company best known for Dermagraft, a cryopreserved human
  fibroblast-derived dermal substitute used to treat diabetic foot ulcers. The company acquired the Dermagraft assets from
  Smith & Nephew in 2006, was backed by Canaan Partners and other venture investors, and was acquired by Shire plc for $750
  million in cash in June 2011 to seed Shire's regenerative medicine business unit. Dermagraft was later sold to Organogenesis
  in 2014. Advanced BioHealing no longer operates as an independent entity and publishes no public developer portal, API,
  or programmatic surface; this profile is retained in the API Evangelist network as a venture-portfolio company record.
url: https://raw.githubusercontent.com/api-evangelist/advanced-biohealing/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Regenerative Medicine
- Biotechnology
- Medical Devices
- Healthcare
- Wound Care
- Life Sciences
- Venture Portfolio
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence